Clinical and biochemical correlates of 'high-dose' clozapine therapy for treatment - Refractory schizophrenia [2]

Schizophrenia Research

Volumn 49, Issue 1-2, 2001, Pages 225-227

  Buckley, P F ^a   Krowinski, A C ^b   Miller, D D ^c   Friedman, L ^a   Eaton, Y ^b   Tronetti, M ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Community Integration Inc ^*  (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; LITHIUM; NORCLOZAPINE; SEROTONIN 2 RECEPTOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADULT; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; MALE; MAXIMUM ALLOWABLE CONCENTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0035871091     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00084-5     Document Type: Letter

References (12)

1. P.F Buckley P Cola M Hasegawa C Lys P Thompson Clozapine plasma levels and dosing strategies in treatment-refractory schizophrenic patients Ir. J. Psyschol. Med. 14 1997 185 188
2. J Endicott R.L Spitzer J.L Fleiss The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance Arch. Gen. Psychiatry 35 1978 837 844
3. M Hasegawa R Gutierrez-Esterinou L Way H.Y Meltzer Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia. Effect of smoking J. Clin. Pyschopharmacol. 13 6 1993 383 390
4. D.W Heinrichs E.T Hanlon W.T Carpenter Jr. The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome Schizophr. Bull. 10 1984 388 398
5. M.H Kronig R.A Munne S Szymanski Plasma clozapine levels and clinical response in treatment-refractory schizophrenia Am. J. Psychiatry 152 1995 179 182
6. D.D Miller F Fleming T.L Holman Plasma clozapine concentrations as a predictor of clozapine response: a follow-up study J. Clin. Psychiatry 55 9, Suppl. B 1994 117 121
7. D.D Miller The clinical use of clozapine plasma concentrations in the management of treatment-refractory schizophrenia Ann. Clin. Psychiatry 8 1996 99 109
8. 2 receptor occupancy in relation to clozapine serum concentrations: a PET study of schizophrenic patients Am. J. Psychiatry 152 1995 1444 1449
9. P.J Perry D.D Miller S.V Arndt Clozapine and non-clozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients Am. J. Psychiatry 148 1991 231 235
10. S.G Potkin R Bera B Gulasekaram Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia J. Clin. Psychiatry 55 9, Suppl. B 1994 133 136
11. B Tarell S.C Schulz Nursing assessment using the BPRS: A structured interview Psychopharmacol. Bull. 24 1 1988 105 111
12. T Van Putten S.R Marder W.C Wirshing M Aravagiri N Chabert Neuroleptic plasma levels Schizophr. Bull. 17 1991 197 216